您的位置: 专家智库 > >

国家自然科学基金(30870731)

作品数:4 被引量:32H指数:3
相关作者:吴湖炳王全师李洪生李葆元王巧愚更多>>
相关机构:南方医科大学南方医院更多>>
发文基金:国家自然科学基金更多>>
相关领域:医药卫生农业科学核科学技术更多>>

文献类型

  • 4篇中文期刊文章

领域

  • 3篇医药卫生
  • 1篇核科学技术
  • 1篇农业科学

主题

  • 3篇脱氧
  • 3篇脱氧葡萄糖
  • 2篇体层摄影
  • 2篇体层摄影术
  • 2篇肿瘤
  • 2篇显像
  • 2篇发射型计算机
  • 2篇PET/C
  • 2篇PET/CT
  • 2篇PET/CT...
  • 2篇^18F
  • 1篇食管
  • 1篇术后
  • 1篇术后复发
  • 1篇肿瘤分期
  • 1篇肿瘤转移
  • 1篇细胞
  • 1篇细胞淋巴瘤
  • 1篇淋巴
  • 1篇淋巴瘤

机构

  • 3篇南方医科大学...

作者

  • 3篇王全师
  • 3篇吴湖炳
  • 2篇李洪生
  • 1篇周文兰
  • 1篇王巧愚
  • 1篇李葆元
  • 1篇王明芳
  • 1篇林丽莉
  • 1篇王丽娟

传媒

  • 1篇中华核医学杂...
  • 1篇核技术
  • 1篇重庆医学
  • 1篇Chines...

年份

  • 1篇2012
  • 2篇2011
  • 1篇2009
4 条 记 录,以下是 1-4
排序方式:
^18F—FDG PET/CT评价弥漫性大B细胞淋巴瘤化疗中期的治疗反应被引量:12
2011年
目的探讨^18F-FDGPET/CT评价弥漫性大B细胞淋巴瘤(DLBCL)患者化疗中期治疗反应的价值。方法DLBCL初诊患者53例,采用环磷酰胺+阿霉素+长春新碱+泼尼松(CHOP)或利妥苷单克隆抗体+环磷酰胺+阿霉素+长春新碱+泼尼松(R-CHOP)方案化疗,分别于化疗前和化疗中期(4个疗程后)进行^18F-FDGPET/CT显像。根据肿瘤对化疗的反应将病例分为完全反应组、部分反应组和无反应组,比较3组患者的完全缓解率。用SPSS13.0软件进行统计学分析,完全缓解率的比较用x2检验。结果完全反应组、部分反应组和无反应组的临床完全缓解率分别为88.5%(23/26)、73.3%(11/15)和8.3%(1/12),3组问差异有统计学意义(X2=23.548,P=0.000)。完全反应组、部分反应组的完全缓解率高于无反应组(X2=22.656,P=0.000和x2=11.407,P=0.001)。结论DLBCL患者化疗中期^18F-FDG PET/CT显像有助于预测其化疗疗效。
李洪生吴湖炳王全师王巧愚李葆元
关键词:淋巴瘤弥漫型体层摄影术体层摄影术脱氧葡萄糖
^(18)F-FDG PET/CT显像对乳腺癌术后复发及转移的诊断价值被引量:6
2011年
目的探讨18F-脱氧葡萄糖正电子发射体层摄影术(FDG PET)/CT显像对乳腺癌术后复发、转移的诊断价值。方法对乳腺癌术后患者104例进行全身18F-FDG PET/CT显像检查。复发或转移灶依据手术或活组织病理学检查、多种影像学检查及临床随访确诊,随访时间大于6个月。结果 104例患者中,肿瘤复发、转移52例。以患者为单位计算,18F-FDG PET/CT诊断乳腺癌术后复发和(或)转移的灵敏度为100%,特异性为98.1%,准确性为99.0%,阳性预测值为98.1%,阴性预测值为100%。以病灶为单位计算,18F-FDG PET/CT诊断乳腺癌术后复发和(或)转移的灵敏度为98.3%,特异性为75.0%,准确性为96.8%,阳性预测值为98.3%,阴性预测值为75.0%1。8F-FDG PET/CT显像使8例(15.4%)患者改变了临床再分期,其中7例提高了临床再分期、1例降低了临床再分期。结论 18F-FDG PET/CT对乳腺癌术后复发和(或)转移的诊断具有重要临床价值。
林丽莉吴湖炳王全师
关键词:复发肿瘤转移脱氧葡萄糖
^11C-methionine and ^18F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas被引量:11
2012年
Background ^18F-fluorodeoxyglucose (FDG) is the most widely used radiotracer in tumor imaging,but its use for brain gliomas and recurrence is limited by the high ^18F-FDG uptake in normal brain tissue.^11C-methionine (MET) has low uptake in the normal brain tissue,providing potential advantages over ^18F-FDG.The aim of the study was to investigate the diagnostic value of ^11C-MET compared to ^18F-FDG positron emission tomography and computed tomography (PET/CT) in patients with suspected primary and residual/recurrent gliomas.Methods Eighty paired PET/CT scans using ^11C-MET and 18F-FDG were performed on 44 newly diagnosed patients with suspected gliomas and 36 post-operative patients with suspected residual/recurrent tumors.PET/CT results were evaluated by visual and semiquantitative analysis.The sensitivity,specificity and accuracy for detection of gliomas and residual/recurrent tumors were calculated using visual analysis.Tumor to contralateral normal gray matter (T/G) ratio was calculated for semiquantitative analysis.Results Final pathology of the 44 newly diagnosed patients included 26 gliomas (14 high-grade and 12 low-grade tumors) and 18 non-glioma benign lesions.Residual/recurrent gliomas were verified in 28 patients and excluded in 8/36 post-operative patients by subsequent histopathologic examination and/or clinical follow-up for more than six months.The sensitivity,specificity and accuracy of 11C-MET PET/CT were 88.5%,83.3% and 86.4% for gliomas and 96.4%,87.5% and 94.4% for residual/recurrent gliomas,respectively.The sensitivity,specificity and accuracy of 18F-FDG PET/CT were 50.0%,88.9% and 65.9% for gliomas and 46.4%,100.0% and 58.3% for residual/recurrent gliomas,respectively.11C-MET had a higher sensitivity than 18F-FDG (83.3% vs.33.3%,P=0.031) in low-grade gliomas,but had no significant difference in sensitivity from 18F-FDG for high-grade gliomas (92.9% vs.64.3%,P=0.219).11C-MET T/G uptake ratios in high-grade gliomas,low-grade gliomas and benign lesions were 1.94±0
LI Dong-liXU Yi-kaiWANG Quan-shiWU Hu-bingLI Hong-sheng
关键词:GLIOMA
^(18)F-FDG PET/CT显像在食管癌分期中的应用被引量:3
2009年
对30例食管癌初诊患者于手术或放化疗前一周内进行18F-FDGPET/CT检查,将15例手术治疗患者的130枚区域淋巴结的PET/CT结果与病理学检查相比较。所有患者的远处转移灶及15例非手术治疗患者的区域淋巴结转移根据活组织病理学检查、多种影像学检查临床随访而定,随访时间均大于6个月。结果显示:30例食管癌患者,原发病灶18F-FDGPET/CT均为高代谢病灶(100%),病灶界限显示清晰。以患者为单位计算,30例食管癌患者,20例(66.7%)证实有区域淋巴结转移,18F-FDGPET/CT真阳性18例,假阳性2例,假阴性2例,诊断的灵敏度、特异性和准确性分别为90.0%、80.0%、86.7%。以淋巴结为单位计算,在15例手术治疗患者的共130枚淋巴结中,病理学检查证实为淋巴结转移33枚(25.4%),PET/CT真阳性23枚。18F-FDGPET/CT对区域淋巴结转移诊断的灵敏度、特异性及准确性分别为69.7%、97.9%、90.8%。检出远处转移4例(13.3%),分布于肝脏、肺及骨骼。30例PET/CT显像后,16例提高了临床分期;1例降低了临床分期;13例与18F-FDGPET/CT显像前的临床分期一致。
王丽娟吴湖炳王全师王明芳周文兰李洪生
关键词:肿瘤分期发射型计算机脱氧葡萄糖
共1页<1>
聚类工具0